Healthcare Analytics Market

Healthcare Analytics Market by Type (Descriptive, Prescriptive, Cognitive), Application (Financial, Operational, RCM, Fraud, Clinical), Component (Services, Hardware), Deployment (On-premise, Cloud), End-user (Providers, Payer) - Global Forecast to 2026

Report Code: HIT 2180 Sep, 2021, by marketsandmarkets.com

[282 Pages Report] The healthcare analytics market is projected to reach USD 75.1 billion by 2026 from an estimated USD 21.1 billion in 2021, at a CAGR of 28.9% during the forecasted period. Healthcare analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, cognitive, and other emerging applied analytical models. Healthcare analytics tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for improved clinical, financial, and operational performance of healthcare organizations. The use of analytics helps healthcare systems reduce healthcare costs and improve the quality of care.

Healthcare Analytics Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Healthcare Analytics Market

The COVID-19 pandemic has had a significant impact on the world’s population and economy. As a result of the pandemic, there has been an increase in the importance of big data in healthcare industry. The predictive and prescriptive analytics has been used to develop prediction models to estimate the emergence of subsequent waves of COVID-19 infection spread in different regions of the world. The increase in the adoption of EHR in developing and developed countries during the pandemic has further influenced the growth of the market in 2020. Operational analytics has proven beneficial in the management of patient data and COVID-19 bed allocation in ICU units during the pandemic. Claim management and risk assessment analytics were widely used in healthcare reimbursement for COVID-19 patients. The healthcare analytics has also witnessed various innovations and developments in the market space owed to the outbreak of the pandemic. All these aforementioned factors have aided the growth of the market in the year 2020.

Drivers: Increasing adoption of EHRin developing and developed countries

In the US, various federal mandates, such as the American Recovery and Reinvestment Act of 2009 (ARRA) and the implementation of ICD-10 code sets are encouraging healthcare organizations to adopt EHRs, focus on the quality of care to comply with pay-for-performance initiatives, and enhance information exchange between various health systems. The implementation of such initiatives is helping providers gather patient data electronically and supporting data integration and chronic disease management. This ultimately helps prevent hospital readmissions and reduces hospital stays, minimizes claims fraud and abuse, improves patient health, and reduces healthcare costs.

Several other federal regulations in the US compel healthcare organizations to focus on digitization and care quality; these include the Health Insurance Portability and Accountability Act (HIPAA) and the Patient Protection and Affordable Care Act (PPACA). The growing need for hospitals in the US to comply with federal healthcare mandates is encouraging them to use data analytics tools for decision-making, improving care quality, and preventing avoidable costs. Since the US is a major contributor to the healthcare analytics market, the implementation of these initiatives is considered a positive indicator of the growth of the overall market.

Restraints: High costs of analytics solutions

Despite the known benefits of analytics in healthcare organizations, its adoption is low among price-sensitive end users owing to the high implementation and subscription/licensing fees of advanced analytics solutions. Only top-tier hospitals have the capability and funding to utilize big data in order to provide actionable insights effectively.

Advanced on-premise healthcare analytics solutions can cost over USD 200,000 for implementation and about the same for annual subscription/licensing fees. This makes it challenging for hospitals to justify their spending on analytics solutions, at least in the short term when they are focused on implementing EHRs and upgrading RCM systems. The impact of this factor is greater in emerging markets where several end users struggle to secure budgets for IT over medical equipment.

Opportunities: Emergence of value based medicines

According to the American Journal of Managed Care, value-based medicine is the practice of medicine based on the objective value (improvement in length of life and/quality of life) conferred by healthcare interventions as determined by utilizing a set of standardized parameters (commonly used to evaluate value and cost-effectiveness). Future healthcare trends are more quality-oriented, focusing on the quality of services provided as well as on generating novel approaches to value-based medicine and care management. Gradually, most hospitals are recognizing the inefficiencies of traditional approaches in patient care, quality assurance, and cost management. Therefore, healthcare BI solutions will be among the top priorities on the investment list of hospitals for logistics management, HIE, and predictive analysis of diseases.

Value-based medicine is redefining healthcare and capturing results-oriented data and making it usable. BI helps healthcare organizations determine what data they need and further helps them to analyze, evaluate, and utilize this data to understand the overall costs versus benefits and gain a competitive advantage. It also enables transparency in all processes to examine every purchase from the standpoint of value, utility, and outcomes.

Challenges: Patient data confidentiality concerns

Patient data contains personal, private, or confidential information that requires strict safeguards to prevent its misuse. The growing use of automated technologies (such as EHRs and medical claims processing), as well as the shifting trend toward health information exchanges (HIEs), have altered the healthcare privacy and security landscape. The electronic exchange of patient data offers greater reach and efficiency in healthcare delivery but involves greater data risk and liability due to broader access and can result in data breaches.

North America holds the largest share in this market

North America dominated the healthcare analytics market, with a share of 61.0% in 2020, followed by Europe and the Asia Pacific. The large share of North America in the global healthcare analytics market can be attributed to the implementation of federal health mandates that encourage the adoption of HCIT solutions, increasing focus on PHM, a significant amount of VC investments, growing pressure to reduce healthcare costs, technological advancements, and high product and service availability in this region. Moreover, most of the leading players in the healthcare analytics market have their headquarters in North America.

Healthcare Analytics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The key players have a strong foothold in the market and offer a wide range of products & services. Some of the key players in this market are IBM (US), Optum (US), Cerner (US), SAS Institute (US), Allscripts (US), McKesson (US), MedeAnalytics (US), Inovalon (US), Oracle (US), Health Catalyst (US), SCIO Health Analytics (US), Cotiviti (formerly Verscend Technologies) (US), CitiusTech (US), Wipro (India), and VitreosHealth (US) among others.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

:

Report Metric

Details

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

By Type, By Application, By Component, By Deployment Model, By End User, & By Region

Geographies covered

North America, Europe, Asia, Pacific countries, Latin America and the Middle East and Africa

Companies covered

The major market players include IBM (US), Optum (US), Cerner (US), SAS Institute (US), Allscripts (US), McKesson (US), MedeAnalytics (US), Inovalon (US), Oracle (US), Health Catalyst (US), SCIO Health Analytics (US), Cotiviti (formerly Verscend Technologies) (US), CitiusTech (US), Wipro (India), and VitreosHealth (US), Linguamatics (US), Flatiron (US), Roam Analytics (US), Komodo Health (US), CVS Health (US) (Total 25 companies)

By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics    
  • Cognitive Analytics

By Application

  • Clinical Analytics
  • Financial Analytics
  • Operation and Administrative Analytics
  • Population Health

By Component

  • Services
  • Hardware
  • Software    

By Deployment Model

  • On-premise
  • On-demand

By End-user

  • Payers
  • Providers
  • ACOs, HIEs, Mcos and TPAs

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia
    • Japan
    • China
    • India
    • RoAPAC
  • Pacific Countries
  • Latin America
  • Middle East & Africa (MEA)

Recent Developments

  • In June 2021, Flatiron (US) Partnered with Foundation Medicine, Inc. to integrate its solutions with OncoEMR to offer integrated genomic profiling to customers.
  • In July 2021, Enlitic (US) partnered with NMC Healthcare (UAE). This is a multi-faceted partnership with private healthcare companies to incorporate Enlitic’s solutions in GCC countries.
  • In May 2020, APIXIO (US) Launched HCC Complete, which uses AI to support a comprehensive chart review experience for Medicare Advantage and Affordable Care Act organizations
  • In November 2020, Centene (US) announced its plans to acquire Apixio (US). Post the acquisition, Apixio will continue to operate independently.
  • In December 2019, Enlitic (US) partnered with MLP Care to bring clinical AI solutions to Turkey and neighboring countries in East Europe and Central Asia

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 35)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
                    FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION
           1.2.2 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 40)
    2.1 RESEARCH APPROACH
    2.2 RESEARCH METHODOLOGY DESIGN
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.2.2.1 Insights from primary experts
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION: HEALTHCARE ANALYTICS MARKET
          FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 7 REVENUE ANALYSIS OF THE TOP THREE PUBLIC COMPANIES: HEALTHCARE ANALYTICS MARKET (2020)
          FIGURE 8 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTHCARE ANALYTICS (US)
          FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HEALTHCARE ANALYTICS MARKET (2021–2026)
          FIGURE 11 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    2.5 MARKET SHARE ESTIMATION
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 LIMITATIONS
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT
          TABLE 1 RISK ASSESSMENT: HEALTHCARE ANALYTICS MARKET

3 EXECUTIVE SUMMARY (Page No. - 54)
    FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
    FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,  2021 VS. 2026 (USD MILLION)
    FIGURE 17 HEALTHCARE ANALYTICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE ANALYTICS MARKET

4 PREMIUM INSIGHTS (Page No. - 59)
    4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
          FIGURE 19 GOVERNMENT INITIATIVES TO INCREASE EHR ADOPTION AND GROWING PRESSURE TO CURB HEALTHCARE COSTS ARE DRIVING MARKET GROWTH
    4.2 FINANCIAL ANALYTICS MARKET SHARE, BY TYPE & REGION (2020)
          FIGURE 20 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE FINANCIAL ANALYTICS MARKET IN 2020
    4.3 HEALTHCARE ANALYTICS MARKET: GEOGRAPHIC MIX
          FIGURE 21 THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
    4.4 REGIONAL MIX: HEALTHCARE ANALYTICS MARKET

5 MARKET OVERVIEW (Page No. - 63)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Government initiatives to increase EHR adoption
                                FIGURE 24 EHR ADOPTION RATE AMONG HEALTHCARE PROVIDERS IN THE US (2012–2020)
                    5.2.1.2 Growing venture capital investments
                    5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes
                                FIGURE 25 HEALTHCARE SPENDING AS A PERCENTAGE OF GDP, BY COUNTRY, 2018
                    5.2.1.4 Big data in healthcare
                    5.2.1.5 Growing focus on real-world evidence
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of analytics solutions
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing focus on value-based medicine
                    5.2.3.2 Use of analytics in precision and personalized medicine
                    5.2.3.3 Cloud-based analytics
                    5.2.3.4 Increasing number of patient registries
                    5.2.3.5 Emergence of social media and its impact on the healthcare industry
                    5.2.3.6 Augmented analytics
                    5.2.3.7 Analytics of Healthcare Things
           5.2.4 CHALLENGES
                    5.2.4.1 Patient data confidentiality
                    5.2.4.2 Concerns regarding inaccurate and inconsistent data
                    5.2.4.3 Reluctance to adopt healthcare analytics solutions in emerging countries
                    5.2.4.4 Data integration
                    5.2.4.5 Operational gaps between payers and providers
                    5.2.4.6 Dearth of skilled personnel

6 HEALTHCARE ANALYTICS MARKET, BY TYPE (Page No. - 73)
    6.1 INTRODUCTION
          TABLE 2 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
    6.2 DESCRIPTIVE ANALYTICS
           6.2.1 DESCRIPTIVE ANALYTICS IS USED TO CONVERT PAST DATA INTO USEFUL INFORMATION
                    TABLE 3 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.3 PREDICTIVE ANALYTICS
           6.3.1 THE INCREASING INCIDENCE OF HEALTHCARE FRAUD IS DRIVING THE MARKET GROWTH FOR PREDICTIVE ANALYTICS
                    TABLE 4 PREDICTIVE ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.4 PRESCRIPTIVE ANALYTICS
           6.4.1 PRESCRIPTIVE ANALYTICS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
                    TABLE 5 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.5 COGNITIVE ANALYTICS
           6.5.1 VENDORS ARE NOW FOCUSING ON INTRODUCING AI-DRIVEN ANALYTICS SOLUTIONS
                    TABLE 6 COGNITIVE ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)

7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT (Page No. - 80)
    7.1 INTRODUCTION
          TABLE 7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
    7.2 SERVICES
          TABLE 8 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 9 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.2.1 SUPPORT SERVICES
                    7.2.1.1 Support services include implementation, ongoing IT support, system integration, training, and maintenance services
                                TABLE 10 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.2.2 BUSINESS ANALYTICS SERVICES
                    7.2.2.1 Business analytics services help healthcare organizations to optimize the use of analytics and drive performance improvement
                                TABLE 11 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.3 SOFTWARE
           7.3.1 HEALTHCARE ANALYTICS SOFTWARE WORKS AS AN INTERFACE BETWEEN THE DATABASE AND END USERS
                    TABLE 12 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.4 HARDWARE
           7.4.1 INCREASING ADOPTION OF CLOUD SERVERS IS EXPECTED TO HINDER THE GROWTH OF THE HARDWARE MARKET FOR ANALYTICS
                    TABLE 13 HEALTHCARE ANALYTICS HARDWARE MARKET, BY REGION, 2019–2026 (USD MILLION)

8 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL (Page No. - 87)
    8.1 INTRODUCTION
          TABLE 14 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
    8.2 ON-PREMISE DEPLOYMENT
           8.2.1 ON-PREMISE DEPLOYMENT MODELS OFFER MULTIVENDOR ARCHITECTURE, WHICH LOWERS THE RISK OF DATA BREACHES & EXTERNAL ATTACKS
                    TABLE 15 ON-PREMISE SOLUTIONS AVAILABLE IN THE MARKET
                    TABLE 16 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE DEPLOYMENT MODEL, BY REGION, 2019–2026 (USD MILLION)
    8.3 ON-DEMAND DEPLOYMENT
           8.3.1 INCREASING VOLUME OF DATA GENERATED ACROSS THE HEALTHCARE PROVIDER INDUSTRY TO DRIVE THE ADOPTION OF ON-DEMAND DEPLOYMENT
                    TABLE 17 ON-DEMAND SOLUTIONS AVAILABLE IN THE MARKET
                    TABLE 18 HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND DEPLOYMENT MODEL, BY REGION, 2019–2026 (USD MILLION)

9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION (Page No. - 91)
    9.1 INTRODUCTION
          TABLE 19 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    9.2 FINANCIAL ANALYTICS
          TABLE 20 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
          TABLE 21 FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 22 FINANCIAL ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.2.1 CLAIMS PROCESSING
                    9.2.1.1 Need to improve claims response time and avoid fraudulent claims will support the use of analytics tools
                                TABLE 23 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
                                TABLE 24 CLAIMS PROCESSING MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.2.2 REVENUE CYCLE MANAGEMENT
                    9.2.2.1 Healthcare organizations are rapidly adopting predictive analytics solutions for proactive decision-making
                                TABLE 25 COMMERCIALLY AVAILABLE RCM SOLUTIONS
                                TABLE 26 REVENUE CYCLE MANAGEMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
                    9.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems will drive market growth
                                TABLE 27 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
                                TABLE 28 PAYMENT INTEGRITY & FWA MARKET, BY REGION,  2019–2026 (USD MILLION)
           9.2.4 RISK ADJUSTMENT & ASSESSMENT
                    9.2.4.1 Risk adjustment & assessment allow for optimization of cash flows and improved financial performance
                                TABLE 29 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
                                TABLE 30 RISK ADJUSTMENT & ASSESSMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.3 CLINICAL ANALYTICS
          TABLE 31 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
          TABLE 32 CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 33 CLINICAL ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
                    9.3.1.1 Benchmarking allows for the identification of issues that are negatively impacting healthcare systems
                                TABLE 34 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
                                TABLE 35 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.3.2 CLINICAL DECISION SUPPORT
                    9.3.2.1 Predictive clinical analytics reduce medical errors and ensure that appropriate tests are performed, a key factor for market growth
                                TABLE 36 COMMERCIALLY AVAILABLE SOLUTIONS FOR CDS
                                TABLE 37 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.3.3 REPORTING & COMPLIANCE
                    9.3.3.1 Stringent regulatory requirements have led to the need for reporting & compliance solutions
                                TABLE 38 REPORTING & COMPLIANCE MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
                    9.3.4.1 Growing adoption of EHRs to provide significant growth opportunities
                                TABLE 39 COMMERCIALLY AVAILABLE COMPARATIVE ANALYTICS/EFFECTIVENESS SOLUTIONS
                                TABLE 40 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.3.5 PRECISION HEALTH
                    9.3.5.1 Strong government support for personalized medicine is likely to drive market growth
                                TABLE 41 COMMERCIALLY AVAILABLE PRECISION HEALTH SOLUTIONS
                                TABLE 42 PRECISION HEALTH MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.3.6 MEDICAL IMAGING ANALYTICS
                    9.3.6.1 Imaging analytics aided by artificial intelligence and machine learning is rapidly expanding within the healthcare IT industry
                                TABLE 43 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
          TABLE 44 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
          TABLE 45 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 46 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.4.1 SUPPLY CHAIN ANALYTICS
                    9.4.1.1 The growing requirement to reduce healthcare costs will increase the adoption of supply chain analytics solutions
                                TABLE 47 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
                                TABLE 48 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.4.2 WORKFORCE ANALYTICS
                    9.4.2.1 Need for real-time resource demand and supply data to drive the adoption of workforce analytics solutions
                                TABLE 49 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
                                TABLE 50 WORKFORCE ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
           9.4.3 STRATEGIC ANALYTICS
                    9.4.3.1 Strategic analytics uses advanced analytics tools to leverage operational and usage data, a key advantage
                                TABLE 51 STRATEGIC ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.5 POPULATION HEALTH ANALYTICS
           9.5.1 POPULATION HEALTH ANALYTICS IMPROVES POPULATION HEALTH OUTCOMES AND LOWERS COSTS, A KEY FACTOR FOR MARKET GROWTH
                    TABLE 52 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
                    TABLE 53 POPULATION HEALTH ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)

10 HEALTHCARE ANALYTICS MARKET, BY END USER (Page No. - 112)
     10.1 INTRODUCTION
             TABLE 54 HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.2 PAYERS
             TABLE 55 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 56 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2019–2026 (USD MILLION)
             10.2.1 PRIVATE INSURANCE COMPANIES
                        10.2.1.1 Private insurance companies accounted for the largest share of the payers market in 2020
                                      TABLE 57 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES, BY REGION, 2019–2026 (USD MILLION)
             10.2.2 GOVERNMENT AGENCIES
                        10.2.2.1 Increasing use of analytics solutions by government agencies to boost the market growth of this end-user segment
                                      TABLE 58 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2019–2026 (USD MILLION)
             10.2.3 EMPLOYERS AND PRIVATE EXCHANGES
                        10.2.3.1 Private exchanges and employers use data analytics for rapid data integration, health plan analysis, and risk modeling
                                      TABLE 59 HEALTHCARE ANALYTICS MARKET FOR EMPLOYERS AND PRIVATE EXCHANGES, BY REGION, 2019–2026 (USD MILLION)
     10.3 PROVIDERS
             TABLE 60 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
                        10.3.1.1 The adoption of healthcare analytics solutions is the highest in large hospitals
                                      TABLE 61 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS, PHYSICIAN PRACTICES, AND IDNS, BY REGION, 2019–2026 (USD MILLION)
             10.3.2 POST-ACUTE CARE ORGANIZATIONS (PACOS)
                        10.3.2.1 PACOs focus on reviewing and studying patient data with the help of healthcare analytics
                                      TABLE 62 HEALTHCARE ANALYTICS MARKET FOR PACOS, BY REGION, 2019–2026 (USD MILLION)
             10.3.3 AMBULATORY SETTINGS
                        10.3.3.1 The need to control healthcare costs to support the market growth of ambulatory settings
                                      TABLE 63 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SETTINGS, BY REGION, 2019–2026 (USD MILLION)
     10.4 ACOS, HIES, MCOS, AND TPAS
             TABLE 64 HEALTHCARE ANALYTICS MARKET FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2019–2026 (USD MILLION)

11 HEALTHCARE ANALYTICS MARKET, BY REGION (Page No. - 124)
     11.1 INTRODUCTION
             TABLE 65 HEALTHCARE ANALYTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
     11.2 NORTH AMERICA
             FIGURE 26 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2020)
             TABLE 66 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 67 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 68 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 69 NORTH AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 70 NORTH AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 71 NORTH AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 72 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 73 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 74 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
             TABLE 75 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             TABLE 76 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 77 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.2.1 US
                        11.2.1.1 High adoption of EHRs to drive the healthcare analytics market in the US
                                      TABLE 78 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 79 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 80 US: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 81 US: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 82 US: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 83 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                      TABLE 84 US: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 85 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                                      TABLE 86 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 87 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 88 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,  2019–2026 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Need for managing patient volumes, clinical data, and healthcare costs will favor market growth in Canada
                                      TABLE 89 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 90 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 91 CANADA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 92 CANADA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 93 CANADA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 94 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                      TABLE 95 CANADA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 96 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                                      TABLE 97 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 98 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 99 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     11.3 EUROPE
             FIGURE 27 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2020)
             TABLE 100 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 101 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 102 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 103 EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 104 EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 105 EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 106 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 107 EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 108 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
             TABLE 109 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             TABLE 110 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 111 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Government initiatives to increase the use of analytics in healthcare are expected to contribute to market growth in Germany
                                      TABLE 112 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 113 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 114 GERMANY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 115 GERMANY: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 116 GERMANY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 117 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                      TABLE 118 GERMANY: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 119 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                                      TABLE 120 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 121 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,  2019–2026 (USD MILLION)
                                      TABLE 122 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Availability of venture capital investments to drive market growth in the UK
                                      TABLE 123 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 124 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 125 UK: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 126 UK: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 127 UK: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 128 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                      TABLE 129 UK: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 130 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                                      TABLE 131 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 132 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 133 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Strong financial support for digital health contributes to the growth in the healthcare analytics market in France
                                      TABLE 134 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 135 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 136 FRANCE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 137 FRANCE: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 138 FRANCE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 139 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,  2019–2026 (USD MILLION)
                                      TABLE 140 FRANCE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 141 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,  2019–2026 (USD MILLION)
                                      TABLE 142 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 143 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 144 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.3.4 REST OF EUROPE
                        TABLE 145 ROE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 146 ROE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 147 ROE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 148 ROE: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 149 ROE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 150 ROE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 151 ROE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 152 ROE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                        TABLE 153 ROE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 154 ROE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 155 ROE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     11.4 ASIA
             FIGURE 28 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2020)
             TABLE 156 ASIA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 157 ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 158 ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 159 ASIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 160 ASIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 161 ASIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 162 ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 163 ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 164 ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
             TABLE 165 ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER,  2019–2026 (USD MILLION)
             TABLE 166 ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 167 ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.4.1 JAPAN
                        11.4.1.1 Rise in the geriatric population will increase the demand for effective patient management solutions
                                      TABLE 168 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 169 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 170 JAPAN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 171 JAPAN: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 172 JAPAN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 173 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                      TABLE 174 JAPAN: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 175 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,  2019–2026 (USD MILLION)
                                      TABLE 176 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 177 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 178 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 Favorable reforms and a growing number of EHRs have contributed to market growth in China
                                      TABLE 179 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 180 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 181 CHINA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 182 CHINA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 183 CHINA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 184 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                      TABLE 185 CHINA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 186 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                                      TABLE 187 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 188 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 189 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 The HCIT market in India is still in the nascent stage
                                      TABLE 190 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 191 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                      TABLE 192 INDIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 193 INDIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 194 INDIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 195 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                      TABLE 196 INDIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE,  2019–2026 (USD MILLION)
                                      TABLE 197 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                                      TABLE 198 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                      TABLE 199 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                                      TABLE 200 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
             11.4.4 REST OF ASIA
                        TABLE 201 ROA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 202 ROA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 203 ROA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 204 ROA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 205 ROA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 206 ROA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 207 ROA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 208 ROA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                        TABLE 209 ROA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 210 ROA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 211 ROA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     11.5 PACIFIC COUNTRIES
             11.5.1 NEED TO REDUCE HEALTHCARE COSTS IN AUSTRALIA AND NEW ZEALAND TO DRIVE MARKET GROWTH IN THIS REGION
                        TABLE 212 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 213 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 214 PACIFIC COUNTRIES: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 215 PACIFIC COUNTRIES: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 216 PACIFIC COUNTRIES: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 217 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 218 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 219 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                        TABLE 220 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 221 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 222 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     11.6 LATIN AMERICA
             11.6.1 GROWING EHEALTH INITIATIVES IN LATAM COUNTRIES TO DRIVE MARKET GROWTH IN THIS REGION
                        TABLE 223 LATAM: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 224 LATAM: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 225 LATAM: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 226 LATAM: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 227 LATAM: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 228 LATAM: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 229 LATAM: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 230 LATAM: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                        TABLE 231 LATAM: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 232 LATAM: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 233 LATAM: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)
     11.7 MIDDLE EAST & AFRICA
             11.7.1 HIGH HEALTHCARE EXPENDITURE AND INFRASTRUCTURAL DEVELOPMENT WILL SUPPORT THE USE OF HCIT SOLUTIONS IN THE MIDDLE EAST
                        TABLE 234 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 235 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 236 MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 237 MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 238 MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 239 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 240 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
                        TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2019–2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 201)
     12.1 INTRODUCTION
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ANALYTICS MARKET
     12.3 MARKET RANKING ANALYSIS
             FIGURE 29 IBM WAS THE LEADING PLAYER IN THE HEALTHCARE ANALYTICS MARKET IN 2020
     12.4 COMPANY EVALUATION MATRIX
             12.4.1 COMPANY EVALUATION MATRIX: HEALTHCARE ANALYTICS MARKET
                        12.4.1.1 Stars
                        12.4.1.2 Pervasive players
                        12.4.1.3 Emerging leaders
                        12.4.1.4 Participants
                        12.4.1.5 Competitive benchmarking
                                     12.4.1.5.1 Overall footprint of companies (20 companies)
                                                     TABLE 245 SERVICE FOOTPRINT OF COMPANIES (20 COMPANIES)
                                                     TABLE 246 END-USER FOOTPRINT OF COMPANIES (20 COMPANIES)
                                                     TABLE 247 REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES)
     12.5 COMPETITIVE SITUATIONS AND TRENDS
             12.5.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
                        TABLE 248 PRODUCT/SERVICE LAUNCHES (JANUARY 2018 TO AUGUST 2021)
             12.5.2 DEALS
                        TABLE 249 DEALS (JANUARY 2018 TO AUGUST 2021)

13 COMPANY PROFILES (Page No. - 212)
     13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 ALLSCRIPTS HEALTHCARE SOLUTIONS
                        TABLE 250 ALLSCRIPTS HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW
                        FIGURE 31 ALLSCRIPTS HEALTHCARE SOLUTIONS: COMPANY SNAPSHOT (2020)
             13.1.2 CERNER CORPORATION
                        TABLE 251 CERNER CORPORATION: BUSINESS OVERVIEW
             13.1.3 COTIVITI, INC. (VERSCEND TECHNOLOGIES)
                        TABLE 252 COTIVITI, INC.: BUSINESS OVERVIEW
             13.1.4 CITIUSTECH INC.
                        TABLE 253 CITIUSTECH INC.: BUSINESS OVERVIEW
             13.1.5 HEALTH CATALYST
                        TABLE 254 HEALTH CATALYST: BUSINESS OVERVIEW
             13.1.6 CVS HEALTH CORPORATION
                        TABLE 255 CVS HEALTH CORPORATION: BUSINESS OVERVIEW
             13.1.7 IBM
                        TABLE 256 IBM: BUSINESS OVERVIEW
             13.1.8 INOVALON
                        TABLE 257 INOVALON: BUSINESS OVERVIEW
                        FIGURE 35 INOVALON: COMPANY SNAPSHOT (2020)
             13.1.9 MCKESSON CORPORATION
                        TABLE 258 MCKESSON CORPORATION: BUSINESS OVERVIEW
             13.1.10 MEDEANALYTICS, INC.
                        TABLE 259 MEDEANALYTICS, INC.: BUSINESS OVERVIEW
             13.1.11 OPTUM, INC.
                        TABLE 260 OPTUM, INC.: BUSINESS OVERVIEW
             13.1.12 ORACLE CORPORATION
                        TABLE 261 ORACLE CORPORATION: BUSINESS OVERVIEW
             13.1.13 SAS INSTITUTE INC.
                        TABLE 262 SAS INSTITUTE INC.: BUSINESS OVERVIEW
             13.1.14 SCIO HEALTH ANALYTICS (AN EXL COMPANY)
                        TABLE 263 SCIO HEALTH ANALYTICS: BUSINESS OVERVIEW
             13.1.15 VITREOSHEALTH, INC.
                        TABLE 264 VITROSHEALTH, INC.: BUSINESS OVERVIEW
             13.1.16 WIPRO
                        TABLE 265 WIPRO: BUSINESS OVERVIEW
                        FIGURE 40 WIPRO: COMPANY SNAPSHOT (2020)
     13.2 OTHER PLAYERS
             13.2.1 FLATIRON
                        TABLE 266 FLATIRON: BUSINESS OVERVIEW
             13.2.2 APIXIO
                        TABLE 267 APIXIO: BUSINESS OVERVIEW
             13.2.3 ENLITIC, INC.
                        TABLE 268 ENLITIC, INC.: BUSINESS OVERVIEW
             13.2.4 KOMODO HEALTH, INC.
                        TABLE 269 KOMODO HEALTH, INC.: BUSINESS OVERVIEW
             13.2.5 HEALTHEC, LLC
                        TABLE 270 HEALTHEC, LLC: BUSINESS OVERVIEW
             13.2.6 SEMA4
             13.2.7 EVIDATION HEALTH, INC.
             13.2.8 INSILICO MEDICINE
             13.2.9 EXSCIENTIA
             13.2.10 AETION, INC.

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 274)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

This study involved four major activities in estimating the size of the healthcare analytics market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers; and annual reports, company house documents, investor presentations, and SEC filings of companies. World Health Organization (WHO) Organisation for Economic Co-operation and Development (OECD), World Analytics Association, Healthcare Data & Analytics Association (HDAA), Health Information and Management Systems Society (HIMSS), International Medical Informatics Association (IMIA), Centers for Medicare & Medicaid Services (CMS), National Association of Health Data Organizations (NAHDO), American Health Information Management Association (AHIMA), Association of Healthcare Providers (AHPI), Canadian Institute for Health Information (CIHI), Canadian Health Care Anti-Fraud Association (CHCAA), Annual Reports, SEC Filings, Investor Presentations, Journals, Publications from Government Sources and Professional Associations, Expert Interviews, and MarketsandMarkets Analysis.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the healthcare analytics market. It was also used to obtain important information about key market players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, and technology and innovation directors of healthcare analytics companies. On the other hand, primary sources from the demand side include industry experts such as directors of hospitals, hospital purchase managers, insurance payers, physicians, and related key opinion leaders.  Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

Healthcare Analytics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the healthcare analytics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Report Objectives

  • To define, describe, and forecast the healthcare analytics market based on type, application, component, deployment model, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall healthcare analytics market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely,
    North America, Europe, Asia, Pacific countries, Latin America, and Middle East and Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments such as product/service launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall healthcare analytics market
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of healthcare analytics market
  • Profiling of additional market players (up to 3)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Healthcare Analytics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Healthcare Analytics Market

Request For Special Pricing
Report Code
HIT 2180
Published ON
Sep, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Healthcare Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved